Medical Licensing (MD/DO) · Independent exam preparation
EBOD Preparation Guide: Clinical Reasoning and Core Science Study Guide
Practise optical calculations, localise visual loss, recognise ocular emergencies and choose investigations and treatments across the comprehensive EBOD syllabus.
By CertMedbry · Updated 19 October 2026
Calculate optical effects, distinguish sight-threatening presentations and connect examination findings to defensible investigations and treatment. This selective guide develops 60 concepts across the ten written themes of the comprehensive European Board of Ophthalmology Diploma Examination. The EBO examination outline and its eight linked syllabus documents define the full scope, including material beyond these selections.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and professional level does this guide cover?
This guide covers the comprehensive European Board of Ophthalmology Diploma Examination, assessing specialist ophthalmic knowledge and clinical skills. FEBO means Fellow of the European Board of Ophthalmology and is the resulting designation, not another examination. FEBOS subspecialty examinations are separate. EBOD has different relationships to national specialist examinations across Europe; it is not a universal medical licence.
How many written questions and response decisions are there?
Part I contains 30 multiple-true/false questions and 30 single-best-answer questions. Each multiple-true/false question has five statements, giving 150 true/false decisions. Each SBA has four options and requires one answer. The 2026 handbook therefore describes 180 response decisions across 60 question stems. It does not identify a separate unscored or pretest allocation.
Structure of Examination · EBOD Exam: Candidate Handbook 2026
How long do the examination components last?
Part I normally lasts two hours. The structure page specifies a two-and-a-half-hour contingency if an onsite technical problem requires paper answer sheets. Part II covers eight cases across four stations: 60 minutes onsite or 80 minutes online, where candidates type responses. Both parts are taken on the same day.
How are the written and clinical components delivered?
The issuer describes electronic delivery through the Speedwell eSystem, subject to contingency arrangements. Onsite clinical cases involve examiner-led discussion; online cases require free-text answers judged against model answers. The published structure specifies question and case counts but does not describe adaptive testing. The 20 questions here are independent SBA learning drills and do not reproduce the multiple-true/false or clinical-case components.
Structure of Examination · EBOD Exam: Candidate Handbook 2026
What do the four clinical stations assess?
The structure page groups cases into: optics, refraction, strabismus, paediatric ophthalmology and neuro-ophthalmology; cornea, external disease, orbit and adnexa; glaucoma, cataract and refractive surgery; and posterior segment, inflammation and uveitis. Each station contains two standardised cases. Candidates may describe findings, formulate a supported differential, select investigations, interpret results or propose management. Answers earn credit for relevant content rather than length.
Structure of Examination · EBOD Exam: Candidate Handbook 2026
How are scores weighted and passing requirements expressed?
Part I contributes 40% and Part II contributes 60%; each clinical station contributes 15% overall. There is no negative marking in Part I. Candidates must achieve a scaled written grade of at least 6 and an overall grade of at least 6. One clinical station may be below 6 under the issuer's stated conditions; the 2026 handbook specifies written and overall scores above 6 for that exception. A scaled grade of 6 is not a fixed raw percentage.
Structure of Examination · EBOD Exam: Candidate Handbook 2026
Which outline and effective dates apply?
The issuer states that the revised comprehensive examination format applies from May 2024. The Candidate Handbook 2026 contains arrangements for the 8 May 2026 Paris sitting. The current syllabus page links eight detailed PDFs without explicit version or effective dates. Examination information supplied as checked on 19 October 2026 should therefore be distinguished from a newly issued or dated syllabus.
Structure of Examination · EBOD Exam: Candidate Handbook 2026 · Syllabus & Recommended Reading
Are official percentages available for the ten written themes?
The supplied official sources list ten written themes without publishing theme percentages. This guide uses six concepts, two questions and two flashcards per theme as an editorial breadth choice. The official 40% written and 60% clinical weights describe assessment components and must not be converted into written-topic percentages. The complete official outline remains the scope reference.
EBOD Exam: Candidate Handbook 2026 · Structure of Examination · Syllabus & Recommended Reading
Which sitting-specific delivery information is currently documented?
The issuer identifies the completed 16 October 2026 examination as fully online. Its current page announces an online examination on 14 May 2027 and an in-person examination in Berlin on 1 October 2027. The May 2026 handbook's Paris venue and tablet arrangements should not be generalised to these sittings. The issuer directs Swiss applicants to SOG.
EBOD is a specialist ophthalmology diploma examination administered by the EBO Education Committee. FEBO is the successful-candidate designation. These independently authored learning materials are not endorsed EBO examination items.
Outline used: Verified on 2026-10-10 against the EBO's current examination and syllabus pages, its Candidate Handbook 2026, and eight currently linked syllabus PDFs. The handbook concerns the May 2026 Paris sitting; the examination structure page states that its revised format applies from May 2024. The syllabus PDFs display no explicit version or effective date. The assigned workbook label maps directly to the comprehensive EBOD Examination; FEBO is the resulting post-nominal designation, not a separate examination.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Optics, Refraction and Contact Lensesnot stated
1.How does focal length determine thin-lens power?
For a thin lens in air, power in dioptres equals the reciprocal of focal length in metres. A converging lens has positive power and a diverging lens negative power under the usual convention. Shorter absolute focal length means greater absolute power, so a 0.25-metre converging lens has twice the power of a 0.50-metre lens. Establishing the medium, units and sign convention before calculating prevents a numerically plausible but physically incorrect answer.
Apply it
A low-vision device contains a thin converging lens with a focal length of 20 centimetres. Convert this to 0.20 metres, then calculate 1/0.20 to identify a power of +5.00 dioptres.
Common pitfall: Using centimetres directly gives the wrong power by a factor of 100. A negative focal length also cannot be discarded merely because power magnitude seems reasonable.
2.When does a converging lens produce a virtual image?
The thin-lens equation relates object distance, image distance and focal length. A real object outside a converging lens's focal point produces a real, inverted image; an object inside the focal distance produces a virtual, upright image. At the focal plane, emerging rays are parallel and the image lies at infinity in the ideal model. These relationships explain why a magnifier works with the object close to the lens rather than at an arbitrary distance.
Apply it
A patient holds print 8 centimetres from a converging magnifier whose focal length is 10 centimetres. Because the print lies inside the focal distance, predict an upright virtual image before attempting a numerical calculation.
Common pitfall: A positive lens does not always form a real image. Image type depends on object position, so power sign alone cannot determine image orientation or location.
3.How does spectacle decentration create prism?
Prentice's rule states that induced prism in prism dioptres equals decentration in centimetres multiplied by lens power in dioptres. The relevant power is that in the meridian of decentration. A plus lens behaves as prisms with their bases toward its optical centre; a minus lens has bases away from its centre. Thus, the calculation gives magnitude while lens sign and viewing position determine base direction. Both are needed to describe the optical effect.
Apply it
An eye looks through a point 5 millimetres below the optical centre of a +4.00-dioptre spherical lens. Use 0.5 × 4 to obtain 2 prism dioptres, with the base directed upward toward the centre.
Common pitfall: Millimetres cannot be inserted directly into Prentice's rule. Reporting only prism magnitude also misses the base direction needed to assess binocular effects.
National Academy of Opticianry: Prentice's Rule and Finding the Power of a Lens in Any Meridian
4.Which power applies in a sphero-cylindrical lens meridian?
A cylindrical lens contributes no power along its axis and its full cylinder power perpendicular to that axis. For a sphero-cylindrical prescription, the axis meridian therefore has the sphere power, while the perpendicular meridian has sphere plus cylinder. Between these principal meridians, the cylinder contribution follows the sine-squared relationship. This matters when evaluating meridional blur or calculating prism: the spherical equivalent does not replace the actual power in the meridian being examined.
Apply it
For a prescription of +2.00/−3.00 × 180, identify +2.00 dioptres horizontally and −1.00 dioptre vertically. A vertical decentration calculation must use the vertical meridional power rather than the sphere alone.
Common pitfall: The cylinder axis names the meridian with no cylinder contribution. Treating it as the meridian of maximum cylinder power reverses the principal powers.
National Academy of Opticianry: Prentice's Rule and Finding the Power of a Lens in Any Meridian
5.Why does vertex distance matter in high prescriptions?
Moving a corrective lens changes the vergence delivered at the cornea, even if its labelled power stays constant. When converting spectacles to a contact lens, the approximation Fcontact = Fspectacle/(1 − dFspectacle) uses the original spectacle vertex distance d in metres. High minus spectacles require less minus at the corneal plane, whereas high plus spectacles require more plus. The effect grows with power and should be considered separately in the principal meridians of an astigmatic prescription.
Apply it
A −10.00-dioptre spectacle correction sits 12 millimetres from the cornea. Calculate −10/(1 + 0.12), approximately −8.93 dioptres, as the optical starting point for contact-lens power before fitting and over-refraction.
Common pitfall: Simply copying a high spectacle prescription to a contact lens ignores the change in lens position. The calculated optical power also does not determine fit or physiological suitability.
EBO syllabus: Optics and Refraction · OpenStax Physics: 16.3 Lenses
6.How can a rigid contact lens improve irregular corneal optics?
Spectacles correct regular refractive error but cannot fully neutralise a highly irregular anterior corneal surface. A rigid contact lens provides a more regular anterior refracting surface, with the intervening tear layer reducing the optical influence of anterior corneal irregularity. Improvement therefore supports an optical contribution to poor acuity, rather than proving that retinal or neural function is normal. Contact-lens correction addresses vision; it does not itself establish that an ectatic cornea has stopped progressing.
Apply it
A young adult with keratoconus has poor spectacle acuity but substantially better acuity during rigid-lens assessment. Explain the optical benefit while arranging separate assessment of corneal progression and ongoing lens tolerance.
Common pitfall: Improved acuity in a rigid lens does not mean the ectasia is stable. Visual rehabilitation and decisions about disease progression answer different clinical questions.
EBO syllabus: Optics and Refraction · Structure of Examination
Paediatric Ophthalmology and Strabismusnot stated
7.Why can unequal childhood visual input cause amblyopia?
Amblyopia develops when abnormal visual experience disrupts visual development, producing reduced vision that is not fully explained by an ocular structural abnormality. Strabismus, unequal refractive error and visual deprivation can each create inadequate or competing input. A child may function well using the better eye, so ordinary behaviour does not exclude a substantial unilateral deficit. Assessment must establish each eye's vision, refractive status, alignment and ocular health before assigning the reduction solely to amblyopia.
Apply it
A child reads comfortably with both eyes open but has markedly reduced acuity in one eye and substantial anisometropia. Explain how the better eye can conceal the deficit and why monocular testing changes the assessment.
Common pitfall: Amblyopia is not a synonym for every unexplained low acuity result. Media opacity, retinal disease and optic-nerve disease require assessment before a developmental explanation is accepted.
8.How do optical correction and occlusion treat different amblyopia mechanisms?
Appropriate refractive correction improves the clarity of the amblyopic eye's input and may itself improve vision. If an interocular deficit persists, patching the better eye or selected penalisation strategies encourage use of the weaker eye. Treatment therefore requires both a usable image and a reason for the developing visual system to use it. Follow-up measures each eye's acuity, treatment adherence and alignment; treatment intensity is individualised rather than inferred from the diagnostic label alone.
Apply it
A child with anisometropic amblyopia receives appropriate spectacles and shows partial improvement. At review, confirm consistent wear and repeat monocular acuity before deciding whether additional treatment to promote weaker-eye use is needed.
Common pitfall: Patching without correcting substantial refractive blur asks the child to use an unclear image. Conversely, prescribing spectacles does not guarantee that every residual amblyopic deficit will resolve.
9.How does hyperopic correction reduce accommodative esotropia?
A hyperopic child may accommodate to obtain a clear image, and accommodation is linked to convergence. Excess accommodative effort can therefore drive an inward deviation. Appropriate hyperopic correction reduces the focusing demand and its associated convergence. Cycloplegic refraction helps reveal the refractive contribution, while alignment measured with correction identifies any residual component. Spectacles are a treatment for the causal optical demand; surgery does not remove the need to correct hyperopia when that demand remains present.
Apply it
A hyperopic child develops an esotropia that becomes straight at distance while wearing the prescribed spectacles. Explain the accommodation-convergence link and assess acuity in each eye rather than interpreting alignment improvement as proof of equal vision.
Common pitfall: Operating before defining the spectacle-corrected deviation can confuse the accommodative and residual components. Good alignment also does not exclude coexisting amblyopia.
10.What does residual near esotropia reveal?
Some children with accommodative esotropia align well at distance in their hyperopic correction but continue to cross at near. This pattern suggests that near accommodative demand produces a relatively strong convergence response. Distance and near measurements must therefore be recorded separately while the child wears the intended correction. Selected children may benefit from a near addition, but suitability depends on the measured pattern and practical use. Persistent deviation should not automatically be classified as spectacle treatment failure.
Apply it
A child is straight when viewing a distant target through spectacles but develops an inward deviation while reading. Repeat near measurements with appropriate targets and evaluate whether reducing near accommodative demand improves alignment.
Common pitfall: A satisfactory distance cover test cannot establish near control. Increasing distance plus without assessing the near pattern may obscure the actual reason for residual crossing.
11.How do cover tests distinguish tropia from phoria?
The cover-uncover test looks for a manifest deviation by observing whether the uncovered eye moves to take up fixation when its fellow is covered. Alternating the cover disrupts fusion and reveals the total dissociated deviation, including a latent component. Interpretation requires a visible fixation target, adequate attention and observation of the correct eye. Testing at distance and near provides information about fixation-dependent differences; prism neutralisation can then quantify the movement rather than merely naming its direction.
Apply it
No refixation occurs during unilateral covering, but alternating the cover produces reproducible horizontal movements. Interpret this as a latent deviation revealed by dissociation, then measure it at both distance and near.
Common pitfall: Movement after alternate covering does not by itself prove a manifest squint. Poor fixation or watching the covered eye instead of the uncovered eye can also mislead interpretation.
12.Why is visual deprivation especially important in childhood cataract?
A visually significant childhood cataract can obstruct the patterned visual input needed for normal visual development. Removing the opacity addresses the obstruction, but the child still needs appropriate optical rehabilitation and assessment for amblyopia. The developmental effect depends on factors such as onset, density and laterality, so the same anatomical label does not imply the same visual prognosis. A poor red reflex or suspected visual-axis opacity requires prompt specialist assessment rather than waiting for reliable letter-chart acuity.
Apply it
An infant has an asymmetric red reflex and a lens opacity obstructing the visual axis. Arrange prompt paediatric ophthalmic assessment and explain that clearing the axis and supporting subsequent visual development are linked treatment goals.
Common pitfall: An anatomically clear visual axis after treatment does not guarantee normal vision. Delayed or inadequate optical rehabilitation can leave the developing visual system without useful focused input.
AAPOS: Amblyopia · EBO syllabus: Paediatric Ophthalmology and Strabismus
External, Corneal and Adnexal diseasenot stated
13.Which features support herpetic epithelial keratitis?
Herpes simplex keratitis can recur because infection may reactivate after latency. A branching dendritic epithelial lesion is a characteristic clue, interpreted alongside symptoms, staining and the rest of the corneal examination. The anatomical layer matters: epithelial disease is not interchangeable with stromal inflammation or other causes of a red eye. Recognition should lead to an assessment directed at herpetic disease and its extent, rather than treatment based only on redness or a history of conjunctivitis.
Apply it
A patient with recurrent unilateral discomfort and photophobia has a branching epithelial lesion on fluorescein examination. Prioritise herpetic keratitis in the differential and document visual acuity and corneal involvement before selecting treatment.
Common pitfall: A branching lesion deserves careful interpretation, but a red eye alone is nonspecific. Recurrent symptoms should not automatically be labelled bacterial conjunctivitis without corneal examination.
14.How does progressive ectasia differ from ordinary refractive change?
Corneal ectasia changes corneal shape and thickness, creating increasingly irregular optics rather than simply a new regular spectacle prescription. Increasing irregular astigmatism, declining spectacle-corrected vision and serial changes in corneal measurements are useful discriminating clues. Corneal imaging and pachymetry help characterise the abnormality and assess change. A single steep reading does not establish progression, and improved vision with a rigid lens does not establish stability. Visual function and structural progression require related but separate assessments.
Apply it
A young adult needs repeated cylinder changes and no longer reaches previous spectacle acuity. Compare serial corneal maps and thickness measurements instead of assuming that another spectacle adjustment fully explains the deterioration.
Common pitfall: One abnormal map identifies concern but does not automatically prove progression. Measurement quality and repeatability must be considered before interpreting small differences as biological change.
EBO syllabus: External Disease, Cornea, Cataract, Refractive surgery · Structure of Examination
15.What does riboflavin-UVA corneal cross-linking aim to change?
Corneal cross-linking combines riboflavin with ultraviolet-A exposure to induce photochemical changes that increase corneal biomechanical stability. The cited PHOTREXA label covers progressive keratoconus and corneal ectasia after refractive surgery using the specified treatment system. Its central purpose is to address ectatic progression, rather than to guarantee spectacle independence or restore a normal corneal shape. Assessment must distinguish the disease-stabilising objective from the patient's separate need for optical correction and visual rehabilitation after treatment.
Apply it
A patient with documented progressive keratoconus asks whether cross-linking will eliminate contact lenses. Explain that stabilising the cornea and correcting its existing irregular optics are separate objectives, even when both contribute to long-term visual function.
Common pitfall: Describing cross-linking as refractive correction creates unrealistic expectations. A treatment intended to limit progression does not necessarily remove pre-existing irregular astigmatism or corneal scarring.
FDA: PHOTREXA VISCOUS and PHOTREXA prescribing information, revised February 2025
16.Why do epithelial healing and protocol-specific safety checks matter in corneal cross-linking?
Epithelial-removal cross-linking temporarily disrupts the cornea's protective barrier, making confirmation of epithelial closure important for detecting delayed healing and ulcerative keratitis. The PHOTREXA/KXL protocol also requires specific checks before ultraviolet irradiation: an observed yellow flare in the anterior chamber after riboflavin preparation and corneal thickness of at least 400 micrometres after epithelial removal and preparation. The yellow flare indicates riboflavin penetration. Irradiation must not proceed unless both requirements are satisfied. These are requirements of this named protocol, rather than universal criteria for every cross-linking technique.
Apply it
If the prepared cornea measures 385 micrometres, the PHOTREXA/KXL protocol requires the labelled additional PHOTREXA instillation and repeat pachymetry until at least 400 micrometres is reached before irradiation. Anterior-chamber yellow flare must also be confirmed. After treatment, worsening pain, reduced vision or a persistent epithelial defect warrants examination for impaired healing and infection.
Common pitfall: A satisfactory preoperative thickness does not establish adequate thickness after epithelial removal and riboflavin preparation. Likewise, elapsed postoperative time or symptom improvement cannot replace examination confirming epithelial-defect resolution.
FDA: PHOTREXA VISCOUS and PHOTREXA prescribing information, revised February 2025
17.How does endothelial failure produce bullous keratopathy?
The corneal endothelium helps maintain stromal deturgescence through its barrier and pump functions. When endothelial function is inadequate, corneal hydration increases, disrupting transparency and reducing vision. Epithelial oedema can form bullae that cause pain when they rupture. This mechanism distinguishes bullous keratopathy from a primary epithelial infection, despite possible surface discomfort in both. Examination should connect the distribution of oedema, epithelial changes and relevant ocular history rather than infer the cause from pain alone.
Apply it
A patient with previous intraocular surgery has diffuse corneal oedema, reduced vision and painful epithelial bullae. Link the surface symptoms to underlying endothelial dysfunction rather than assuming that the bullae represent a primary inherited epithelial disorder.
Common pitfall: Painful epithelial changes do not make this primarily an epithelial disease. Treating only surface discomfort overlooks the deeper mechanism responsible for persistent loss of corneal transparency.
EBO syllabus: External Disease, Cornea, Cataract, Refractive surgery · Structure of Examination
18.When should a contact-lens-associated red eye raise concern for keratitis?
Contact-lens wear is relevant when redness is accompanied by pain, photophobia, reduced vision or a corneal lesion. These findings require assessment for corneal infection rather than an assumption of uncomplicated conjunctivitis. Fungal keratitis is one possible infection, and diagnostic assessment may include corneal sampling. The exposure history, lens practices and examination guide the differential; lens use alone does not identify an organism. Unnecessary corticosteroid treatment can worsen fungal infection and should not substitute for establishing the cause.
Apply it
A contact-lens wearer develops unilateral pain, blur and a corneal opacity. Arrange prompt corneal assessment, document lens-related exposures and consider appropriate sampling rather than offering reassurance based on the absence of purulent discharge.
Common pitfall: An apparently modest red eye can still involve the cornea. Empirical anti-inflammatory treatment may mask or aggravate infection when the underlying organism has not been considered.
Glaucoma, Cataract and Refractive Surgerynot stated
19.How is a glaucoma target pressure individualised?
A target intraocular pressure estimates the pressure likely to slow damage enough to preserve useful vision over the patient's expected lifetime. It depends on disease stage, baseline pressure, progression rate, life expectancy and treatment burden. The target is revisable: demonstrated progression can justify a lower target even when measured pressure previously seemed satisfactory. A population reference range is therefore insufficient for deciding whether an individual eye is adequately controlled, especially when existing damage is advanced or worsening quickly.
Apply it
An eye with advanced glaucoma continues to lose field despite pressures previously accepted as satisfactory. Review measurement quality and progression, then reconsider the target in light of the remaining visual reserve and observed rate of loss.
Common pitfall: A pressure below a conventional threshold is not proof of disease control. Target pressure is a clinical estimate that must be tested against structural and functional outcomes.
20.How should structural and functional glaucoma findings be combined?
Glaucoma assessment combines optic-nerve and retinal nerve fibre layer findings with visual-field function. These measurements sample different aspects of disease and need not become abnormal simultaneously. Serial testing helps distinguish progression from noise, while examination and image review identify artefacts or alternative explanations. A convincing change should be interpreted in its anatomical context rather than accepted solely because software flags it. Conversely, one apparently stable test does not invalidate a reproducible abnormality documented by another assessment method.
Apply it
An OCT report flags new thinning, but the scan has poor signal and segmentation errors while repeated fields remain unchanged. Review the raw images and repeat reliable testing before labelling the apparent change as progression.
Common pitfall: Automated colour coding is not a diagnosis. Dismissing all structural change because the field remains normal can be equally misleading when high-quality serial imaging shows reproducible loss.
21.Why must tonometry be interpreted with corneal findings?
Tonometry estimates intraocular pressure through interaction with the cornea, so corneal thickness, biomechanics and surface condition influence interpretation. Pachymetry supplies relevant context but does not convert every reading into a uniquely correct pressure using a universal adjustment. Refractive surgery and corneal pathology can make an apparently reassuring value less straightforward. Pressure should therefore be interpreted alongside technique, corneal history, angle findings and evidence of optic-nerve damage, rather than treated as an isolated numerical diagnosis of glaucoma.
Apply it
A patient with previous corneal refractive surgery has suspicious optic-disc changes despite a low measured pressure. Record the surgical history and assess corneal and glaucomatous findings rather than excluding glaucoma from the tonometry result.
Common pitfall: A thickness-based arithmetic correction cannot capture every biomechanical effect. Neither a single pressure measurement nor a calculated corrected value replaces assessment of the optic nerve and visual field.
EBO syllabus: Glaucoma · EBO syllabus: External Disease, Cornea, Cataract, Refractive surgery
22.How does gonioscopy distinguish glaucoma mechanisms?
Gonioscopy examines the anterior chamber angle and helps establish whether the trabecular drainage region is open, obstructed by iridotrabecular contact or altered by secondary pathology. This anatomical information changes the explanation for pressure elevation and the choice of treatment. Peripheral anterior synechiae represent established adhesion rather than merely transient apposition. A pressure reading and optic-disc appearance alone cannot provide this distinction, so an eye should not be classified as open-angle solely because the central chamber appears reasonably deep.
Apply it
A patient has elevated pressure and glaucomatous damage, but the mechanism is uncertain. Examine the angle for contact, synechiae and secondary changes before treating the diagnostic label as established primary open-angle glaucoma.
Common pitfall: Central chamber depth is an incomplete proxy for angle anatomy. Assuming every elevated pressure has the same outflow mechanism can lead to an inappropriate management plan.
23.Why does pseudoexfoliation change cataract planning?
Pseudoexfoliation is associated with poor pupillary dilation and zonular weakness, which can complicate cataract surgery. Preoperative assessment should look for these mechanical risks as well as associated pressure or glaucomatous problems. Lens instability matters because zonules support the capsular bag during surgery and later support the implanted lens complex. Identifying pseudoexfoliation therefore affects operative preparation and counselling even when the cataract itself looks routine and the patient's current intraocular pressure is within the measured reference range.
Apply it
An eye with pseudoexfoliative material has a small dilated pupil and subtle lens wobble. Anticipate limited access and weakened support when planning surgery, rather than assessing operative risk from lens opacity alone.
Common pitfall: Pseudoexfoliation is not merely a pressure-related diagnosis. A currently satisfactory pressure does not remove the separate surgical risks from poor dilation and zonular instability.
24.Which corneal findings matter before refractive surgery?
A refractive procedure changes corneal optics and may alter biomechanical reserve, so a stable spectacle prescription alone is insufficient for selection. Corneal shape, thickness, ocular surface condition and evidence of ectasia must be assessed alongside the planned correction. Irregular or suspicious measurements require explanation before proceeding. The purpose of preoperative testing is both optical and structural: a patient may have a correctable refractive error yet still have a cornea unsuitable for the proposed tissue-altering procedure.
Apply it
A prospective refractive-surgery patient has excellent spectacle acuity but asymmetric corneal steepening on repeated maps. Investigate the corneal abnormality before choosing surgery, rather than treating good corrected acuity as proof of structural suitability.
Common pitfall: A favourable refractive outcome estimate does not establish biomechanical safety. Normal-looking central thickness alone cannot neutralise suspicious shape or other evidence of corneal disease.
EBO syllabus: External Disease, Cornea, Cataract, Refractive surgery
Retina, Vitreous and Uveanot stated
25.How does a retinal break cause rhegmatogenous detachment?
Rhegmatogenous retinal detachment occurs when a full-thickness retinal break allows fluid to pass beneath the neurosensory retina and separate it from the underlying retinal pigment epithelium. Vitreoretinal traction can contribute to creating the break. The mechanism differs from tractional separation without a primary break or exudative accumulation of fluid. Recognising the mechanism matters because assessment must locate the detachment and associated breaks rather than treating all retinal elevation as one disease with an interchangeable management pathway.
Apply it
A patient develops flashes followed by a peripheral field shadow, and examination finds elevated retina with a tear. Explain that the tear provides a route for fluid beneath the retina and requires urgent retinal management.
Common pitfall: Retinal elevation alone does not prove a rhegmatogenous mechanism. The presence or absence of a break and traction must be assessed rather than inferred from symptoms alone.
NIH: Retinal Detachment · EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases
26.How does tractional detachment differ from break-related detachment?
Tractional detachment results when contracting tissue pulls the retina away from its underlying support. Advanced proliferative diabetic retinopathy can create fibrovascular tissue that produces this traction. A retinal break is not required for the primary mechanism, although combined tractional and rhegmatogenous disease can occur. The distinction prevents an oversimplified assumption that every detached retina began with a tear. Assessment must identify the distribution of traction, retinal involvement and any coexisting break to understand the actual anatomy.
Apply it
An eye with advanced diabetic retinopathy has retinal elevation beneath contracting fibrovascular tissue. Describe the tractional mechanism and assess for associated breaks rather than assuming that a peripheral tear must explain the entire detachment.
Common pitfall: The absence of an identified tear does not exclude retinal detachment. Conversely, diabetes does not guarantee a purely tractional process; mixed mechanisms remain possible.
National Eye Institute: Diabetic Retinopathy · EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases
27.When do flashes and floaters require urgent retinal assessment?
New flashes, a sudden increase in floaters or a shadow across the visual field can signal a retinal tear or detachment. Retinal detachment may be painless, so lack of discomfort is not reassuring. A curtain-like defect particularly suggests loss of functioning attached retina in the corresponding field. Symptoms require timely dilated retinal assessment rather than a diagnosis based solely on history; an early tear may exist before the patient notices a large field defect or major acuity reduction.
Apply it
A patient reports a sudden shower of floaters and a dark curtain from one side, without pain. Arrange urgent retinal assessment and explain that preserved central reading vision does not rule out a serious peripheral detachment.
Common pitfall: Waiting for pain or central visual loss can delay recognition. A normal anterior segment examination does not evaluate the peripheral retina where the causative break may lie.
28.How does the anatomical distribution of inflammation classify uveitis?
Anatomical classification follows the predominant site of inflammation. Anterior uveitis primarily involves the anterior chamber; intermediate uveitis primarily involves the vitreous; posterior uveitis primarily involves the retina or choroid. Panuveitis requires inflammation involving the anterior chamber, vitreous, and retina or choroid without a predominant site. Involvement of two compartments alone does not meet this definition. Classification describes the inflammatory distribution and helps organise the differential diagnosis, but does not establish whether the cause is infectious or noninfectious.
Apply it
Anterior-chamber cells together with substantial vitreous inflammation, but no retinal or choroidal inflammation, can represent combined anterior and intermediate uveitis. This should not be called panuveitis merely because two regions are involved. In contrast, inflammation in the anterior chamber, vitreous, and retina or choroid, with no predominant site, supports panuveitis.
Common pitfall: Do not classify macular oedema alone as proof of posterior uveitis: it can complicate inflammation whose primary site is elsewhere. Distinguish the primary inflammatory site from secondary complications and document the findings in each compartment.
National Eye Institute: Uveitis · EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases · AAOSub_2022_RET_Syllabus_Uveitis.pdf
29.Why must infection remain in a uveitis differential?
Intraocular inflammation can result from infection or immune-mediated disease, and corticosteroids alone can permit an untreated pathogen to cause further tissue destruction. Diagnostic reasoning should combine immune status, lesion morphology, anatomical location and time course. In an immunosuppressed patient, granular white retinal necrosis with intraretinal haemorrhage, particularly along retinal vessels, raises suspicion for cytomegalovirus (CMV) retinitis. Vitreous inflammation may be modest despite extensive infection. HSV/VZV necrotizing retinitis and toxoplasmosis are important competing infectious diagnoses.
Apply it
A patient receiving immunosuppression for presumed noninfectious uveitis develops floaters and an enlarging haemorrhagic white retinal lesion with little vitritis. Suspect CMV retinitis rather than assuming an inflammatory relapse. When the appearance is atypical or the pathogen remains uncertain, aqueous or vitreous PCR directed at CMV, HSV, VZV and toxoplasma can clarify the diagnosis and guide treatment. Arrange urgent specialist management and pathogen-directed antiviral treatment when CMV is strongly suspected; sight-threatening disease should not await a laboratory result before treatment begins.
Common pitfall: Reduced redness, pain or vitreous cells after corticosteroids does not establish a noninfectious cause. These findings can improve while retinal infection progresses. Increasing corticosteroids alone does not treat CMV; anti-inflammatory treatment, when needed, must accompany appropriate pathogen-directed therapy.
National Eye Institute: Uveitis · EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases · AAOSub_2022_RET_Syllabus_Uveitis.pdf
30.How does diabetic macular oedema reduce central vision?
Diabetic retinal vascular injury can allow fluid to leak into the macula, producing swelling that impairs central vision. This differs from visual obscuration by vitreous haemorrhage and from retinal separation caused by traction. OCT helps show retinal thickening and fluid, connecting symptoms to macular anatomy. Diabetic macular oedema can accompany different retinopathy stages, so its presence and effect should be assessed separately from whether proliferative new vessels are visible during the same examination.
Apply it
A patient with diabetes has gradual central blur and OCT evidence of macular fluid without vitreous haemorrhage. Identify macular oedema as the immediate anatomical explanation while also grading the wider retinopathy.
Common pitfall: The absence of visible proliferative vessels does not exclude a sight-threatening macular complication. Central blur should not be attributed to glucose-related refractive fluctuation without examining the retina.
National Eye Institute: Diabetic Retinopathy · EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases
Neuro-ophthalmologynot stated
31.Why does a chiasmal lesion cause bitemporal field loss?
Fibres from the nasal halves of the retinas cross at the optic chiasm and carry information from the temporal visual fields. A chiasmal lesion can therefore produce temporal field loss in both eyes, commonly respecting the vertical meridian. The pattern localises the problem but does not establish its cause or guarantee perfect symmetry. Acuity may remain relatively preserved early, making formal field assessment important when symptoms or associated features suggest a lesion near the chiasm.
Apply it
A patient retains good central acuity but has reproducible temporal field defects in both eyes respecting the vertical meridian. Localise the deficit to the chiasmal region and select investigation directed at that anatomy.
Common pitfall: Good visual acuity does not exclude a major field defect. Bitemporal loss should not be described as homonymous because the missing sides differ between the two eyes.
32.How does homonymous field loss identify a retrochiasmal lesion?
Each retrochiasmal visual pathway carries information from the opposite half of visual space in both eyes. A lesion on the right can therefore cause left homonymous field loss, whereas a left-sided lesion can cause right homonymous loss. The field side localises the cerebral hemisphere; additional features help refine the site along the tract, radiations or cortex. Congruity is informative but not an infallible stand-alone rule, and field interpretation must include test reliability and the broader neurological examination.
Apply it
Reliable fields show loss of the left half of visual space in each eye. Localise the lesion to the right retrochiasmal pathway rather than to the left eye, then integrate onset and neurological findings.
Common pitfall: Naming the affected hemisphere from the eye with more obvious symptoms can reverse localisation. Homonymous describes matching visual-field sides, not matching nasal or temporal retinal halves.
33.How does the swinging-flashlight test reveal an afferent defect?
The swinging-flashlight test compares the afferent light signal from the two eyes while observing pupillary responses. If one eye sends a weaker signal, moving the light from the better eye to that eye produces less constriction or relative dilation of both pupils. This is a relative afferent pupillary defect. It indicates asymmetric afferent dysfunction, commonly involving the optic nerve or substantial retinal disease, rather than a problem defined by unequal resting pupil sizes or failure of one iris to constrict.
Apply it
Both pupils constrict well when the right eye is illuminated but partially redilate when the light moves to the left. Identify a left relative afferent defect even if resting pupil sizes are equal.
Common pitfall: Equal pupils do not exclude an afferent defect. Bilateral symmetric afferent disease can also produce severe visual dysfunction without a relative defect between the eyes.
Stanford Neuro-Ophthalmology: Pupils—Examination, Anatomy and Physiology
34.How do direct and consensual responses distinguish efferent dysfunction?
Light entering either healthy eye activates bilateral pupillary constriction through the central light-reflex pathway. With an isolated efferent defect affecting one pupil, that pupil constricts poorly regardless of which eye receives the light, while the fellow pupil can respond to illumination of either eye if afferent function is intact. This separates failure of the motor output from weak sensory input. Testing both illumination directions and watching both pupils is therefore more informative than recording a single absent direct response.
Apply it
The left pupil remains poorly reactive when either eye is illuminated, but the right pupil constricts to light in either eye. Identify a left efferent problem rather than assuming the left optic nerve cannot detect light.
Common pitfall: An absent direct response alone does not localise the lesion. The consensual response and the fellow pupil's behaviour are necessary to separate input from output failure.
Stanford Neuro-Ophthalmology: Pupils—Examination, Anatomy and Physiology
35.Which findings make optic neuropathy more likely than isolated blur?
Optic neuropathy is supported by a coherent combination of visual dysfunction, field abnormality and afferent findings rather than reduced acuity alone. A relative afferent pupillary defect is especially useful when involvement is asymmetric, but substantial retinal disease can produce it too. The optic disc may not immediately reveal every optic-nerve lesion, so a normal-looking disc cannot independently settle the question. Localisation requires integrating the pupil examination with retinal assessment, visual fields, history and other neurological findings.
Apply it
A patient has unilateral visual reduction, a reproducible field defect and an afferent pupillary defect, but no adequate media explanation. Investigate retinal and optic-nerve causes rather than concluding that a clear cornea and lens establish normal ocular function.
Common pitfall: A relative afferent defect supports afferent pathway asymmetry but is not exclusive to optic-nerve disease. A normal disc appearance also does not exclude retrobulbar dysfunction.
EBO syllabus: Neuro Ophthalmology · Stanford Neuro-Ophthalmology: Pupils—Examination, Anatomy and Physiology
36.How does a sixth-nerve palsy differ from a horizontal gaze palsy?
A sixth-nerve palsy impairs abduction of the affected eye and can produce horizontal diplopia, often more evident at distance. A lesion involving the sixth-nerve nucleus can impair conjugate gaze toward that side because the nucleus participates in coordinating both eyes. Associated cranial-nerve findings further refine localisation: combinations involving ocular motor nerves and trigeminal function may suggest a cavernous sinus process. Describing the movement pattern and associated signs is therefore more useful than labelling every abduction problem identically.
Apply it
One patient cannot abduct the right eye; another cannot move either eye to the right and also has ipsilateral facial weakness. Recognise that the second pattern suggests a more central lesion than an isolated peripheral sixth-nerve palsy.
Common pitfall: An abduction deficit is a finding, not a complete localisation. Mechanical restriction and central gaze disorders must be considered before assuming an isolated peripheral nerve lesion.
EBO syllabus: Neuro Ophthalmology · Structure of Examination
Orbital Disease and Oculoplastic Surgerynot stated
37.Which findings distinguish orbital from preseptal cellulitis?
Preseptal cellulitis affects tissues anterior to the orbital septum, whereas orbital cellulitis involves deeper orbital tissues and can threaten vision or spread intracranially. Painful or restricted eye movements, proptosis and visual impairment raise concern for orbital involvement. Eyelid redness and swelling occur in both and cannot establish the distinction. Suspected orbital disease requires urgent hospital-level assessment, with imaging and systemic treatment guided by the clinical picture rather than an assumption that all swollen eyelids represent a superficial infection.
Apply it
A child with fever and swollen lids has pain on eye movement and reduced ocular motility. Treat these findings as evidence of possible orbital involvement and arrange urgent hospital assessment rather than relying on lid appearance alone.
Common pitfall: The amount of lid swelling does not reliably determine depth of infection. Limited examination in an unwell child should not be interpreted as reassuring normal orbital function.
38.How can thyroid eye disease threaten the optic nerve?
Thyroid eye disease can cause dysthyroid optic neuropathy when enlarged orbital tissues crowd the apex and compromise optic-nerve function. Reduced acuity, colour or field function and an afferent defect when asymmetric require urgent attention. The degree of visible proptosis is not a reliable measure of apical crowding, so an eye need not look dramatically protruding to be threatened. Assessment must separate optic neuropathy from other causes of reduced vision, including exposure-related corneal disease.
Apply it
A patient with thyroid eye disease develops colour desaturation and a new field defect despite modest proptosis. Assess urgently for optic neuropathy and apical crowding rather than grading risk from external appearance alone.
Common pitfall: Marked proptosis is not required for optic-nerve compromise. Symmetric bilateral dysfunction can also reduce the usefulness of a relative afferent defect as a warning sign.
Management of Thyroid Eye Disease: ATA–ETA Consensus Statement, 2022
39.Why does incomplete eyelid closure endanger the cornea?
Effective blinking and eyelid closure distribute tears and protect the corneal surface. Proptosis, lid retraction or impaired closure can increase exposure, destabilise the tear film and lead to epithelial breakdown. In thyroid eye disease, corneal exposure is a distinct threat from optic neuropathy and requires its own assessment. Surface protection depends on severity and may include lubrication and measures to improve closure; epithelial defects or worsening visual function require escalation rather than treatment based solely on discomfort.
Apply it
A patient with thyroid eye disease reports morning pain and cannot fully close the lids. Examine for exposure-related staining or epithelial defects and institute protection appropriate to the actual corneal findings.
Common pitfall: Comfort does not reliably measure corneal integrity. Treating orbital inflammation alone may leave a persistent mechanical exposure problem that continues to damage the surface.
Management of Thyroid Eye Disease: ATA–ETA Consensus Statement, 2022
40.Why are smoking and thyroid control relevant to orbitopathy?
Smoking is an important modifiable risk factor associated with thyroid eye disease and poorer outcomes. Maintaining stable thyroid function is also part of coordinated care, but thyroid biochemical control and orbital disease activity are not interchangeable measurements. A patient may need ongoing ocular assessment even after thyroid tests improve. Counselling should connect smoking cessation and endocrine management to eye care while continuing to monitor vision, motility, exposure and evidence of optic-nerve compromise.
Apply it
A smoker with newly diagnosed thyroid eye disease assumes normalised thyroid tests will end all ocular follow-up. Explain the separate course of orbital disease and incorporate smoking cessation and endocrine coordination into the care plan.
Common pitfall: Normal thyroid biochemistry does not prove inactive or harmless orbitopathy. Risk modification complements examination and treatment; it does not replace assessment of current sight-threatening complications.
Management of Thyroid Eye Disease: ATA–ETA Consensus Statement, 2022
41.How do pupil and ocular-movement patterns localise the cause of ptosis?
Examine pupil size and reactions in bright light and darkness, together with ocular movements. Ptosis with ipsilateral miosis suggests Horner syndrome: sympathetic dysfunction weakens pupillary dilation and the sympathetically innervated superior tarsal muscle. Anisocoria is typically greater in darkness because the smaller pupil dilates poorly. Ptosis with a larger, poorly reactive pupil and impaired adduction, elevation or depression suggests third-nerve dysfunction. Here, parasympathetic dysfunction impairs constriction, making anisocoria more apparent in bright light. The accompanying levator and extraocular-muscle weakness distinguishes this pattern from isolated pupillary dilation.
Apply it
A 55-year-old develops sudden painful right ptosis and diplopia. The right pupil is 6 mm and poorly reactive, compared with a briskly reactive 3 mm left pupil; right adduction and elevation are impaired. This is an acute pupil-involving third-nerve palsy requiring emergency vascular imaging with CTA or MRA to exclude an intracranial aneurysm, particularly a posterior communicating artery aneurysm.
Common pitfall: Do not classify an unequal pupil without comparing both lighting conditions. The smaller pupil may be abnormal in Horner syndrome, whereas the larger pupil is abnormal in a pupil-involving third-nerve palsy. Normal pupils alone do not establish that acute ptosis with ophthalmoplegia is benign.
EBO syllabus: Eyelids, Lacrimal system, Orbit · EBO syllabus: Neuro Ophthalmology · Stanford Neuro-Ophthalmology: Pupils—Examination, Anatomy and Physiology
42.How can tearing arise from both surface disease and drainage failure?
Epiphora can result from increased tear production, inadequate drainage or a combination of mechanisms. Ocular surface irritation may stimulate reflex tearing even when the patient also describes dryness. Lid malposition, punctal problems and obstruction elsewhere in the lacrimal pathway can impair drainage. Assessment therefore links the tear meniscus, surface condition, lid position and drainage findings rather than equating every watery eye with the same obstruction. The mechanism determines whether treatment should address irritation, lid function or the drainage pathway.
Apply it
A patient reports watering and burning, with surface staining but no clear evidence of drainage obstruction. Assess the ocular surface and lid function before proposing a drainage procedure solely because tears overflow.
Common pitfall: Watering does not exclude ocular surface dryness. Conversely, identifying irritation does not rule out a simultaneous drainage problem when the history and examination suggest both mechanisms.
General Medicine relevant to Ophthalmologynot stated
43.Which clinical combination raises concern for giant cell arteritis?
Suspect giant cell arteritis in an adult aged 50 years or older with new headache, scalp tenderness or jaw claudication accompanied by transient or persistent visual disturbance. Jaw claudication means aching or fatigue provoked by chewing and relieved by rest, reflecting ischaemia rather than nonspecific jaw tenderness. Sudden visual loss with a pale swollen optic disc supports arteritic anterior ischaemic optic neuropathy. Constitutional symptoms and raised inflammatory markers strengthen suspicion, but absence of headache or a normal inflammatory marker does not independently exclude the disease.
Apply it
A 74-year-old reports transient monocular darkening, a new temporal headache and jaw fatigue after several mouthfuls of food. This coherent ischaemic pattern warrants urgent assessment, including visual acuity, pupils, fundus examination, inflammatory markers and confirmatory investigation. When clinical suspicion is high, begin glucocorticoids without waiting for confirmation. The ACR/Vasculitis Foundation guideline conditionally favours intravenous pulse glucocorticoids when vision is threatened. Arrange temporal artery biopsy promptly, preferably within two weeks after treatment starts.
Common pitfall: Recovered acuity after transient visual loss does not remove the risk of permanent loss or fellow-eye involvement. Glucocorticoids do not immediately erase biopsy findings, and the two-week preference is not an absolute diagnostic expiry. Treatment response alone neither confirms nor excludes arteritis.
2021 ACR/Vasculitis Foundation Guideline for Giant Cell Arteritis and Takayasu Arteritis
44.Why should suspected arteritic visual ischaemia be treated before confirmation?
When giant cell arteritis is strongly suspected with threatened vision, treatment aims to prevent additional irreversible ischaemic damage while diagnostic work proceeds. The ACR/Vasculitis Foundation guideline conditionally favours intravenous pulse glucocorticoids over high-dose oral treatment for newly diagnosed disease with threatened vision. This recommendation depends on clinical context and evidence certainty; it is not a universal regimen for every headache or every form of visual loss. Definitive investigation should be organised without allowing it to delay urgent treatment.
Apply it
A patient with a strongly suggestive giant cell arteritis presentation develops new visual loss while diagnostic testing is being arranged. Begin urgent specialist-directed glucocorticoid treatment and pursue confirmation in parallel rather than waiting for pathology.
Common pitfall: Diagnostic certainty is not a prerequisite for protecting threatened vision when suspicion is high. The conditional recommendation should also not be presented as an inflexible treatment rule.
2021 ACR/Vasculitis Foundation Guideline for Giant Cell Arteritis and Takayasu Arteritis
45.How should temporal artery biopsy be timed and interpreted after glucocorticoids have started?
Temporal artery biopsy can remain diagnostically useful after glucocorticoid treatment begins because histological abnormalities do not disappear immediately. The ACR/Vasculitis Foundation guideline conditionally recommends biopsy within two weeks of starting oral glucocorticoids when feasible, while recognising that diagnostic changes can persist beyond this interval. Two weeks is therefore a preferred investigation window, not an absolute expiry date. A negative biopsy does not automatically exclude giant cell arteritis: segmental involvement can leave the sampled artery without diagnostic inflammation, so interpretation must incorporate the clinical probability and other diagnostic evidence.
Apply it
A patient with suspected giant cell arteritis and threatened visual ischaemia starts treatment immediately and has biopsy arranged five days later. Continue necessary treatment and proceed with biopsy; treatment has not made the specimen pointless. If the result is negative despite persistent clinical suspicion, reassess the complete diagnostic evidence rather than declaring the disease excluded.
Common pitfall: Do not delay treatment of threatened visual ischaemia to obtain an untreated specimen, or interrupt necessary glucocorticoids simply to improve biopsy yield. Conversely, do not interpret a biopsy obtained after two weeks as automatically uninformative. Treatment timing and sampling limitations affect interpretation without creating a universal diagnostic cutoff.
2021 ACR/Vasculitis Foundation Guideline for Giant Cell Arteritis and Takayasu Arteritis
46.How do systemic risk factors influence diabetic retinal disease?
Diabetes damages retinal blood vessels, and systemic risk management helps reduce the chance of developing or worsening diabetic retinopathy. Glycaemic control, blood-pressure management and cholesterol management belong alongside eye-specific assessment and treatment. These measures address disease risk over time but do not establish the current retinal state. A patient with apparently satisfactory recent laboratory results may still have established retinal damage, so systemic improvement and ophthalmic surveillance should be understood as complementary parts of care.
Apply it
A patient with diabetic retinopathy asks whether improved blood glucose means retinal treatment can be abandoned. Explain the value of systemic control while basing ocular follow-up and intervention on the current retinal findings.
Common pitfall: One improved laboratory measurement does not reverse all previous vascular injury. Eye treatment also cannot substitute for addressing the systemic factors that influence continuing retinal risk.
47.Why can good vision coexist with diabetic retinopathy?
Diabetic retinopathy may be asymptomatic during early stages, and peripheral retinal abnormalities need not immediately reduce central visual acuity. Waiting for blur therefore selects a late or complication-driven detection strategy. Dilated retinal assessment can identify disease before the patient notices symptoms, while follow-up is determined by retinal status and the relevant screening or clinical programme. Symptom-free vision is useful information about current function but is not a reliable substitute for examining the retinal vasculature.
Apply it
A person with longstanding diabetes declines retinal assessment because reading vision remains excellent. Explain that preserved central acuity can coexist with retinopathy and that examination aims to identify treatable disease before symptoms develop.
Common pitfall: Acuity testing samples central visual performance rather than the entire retina. The absence of blur does not establish absence of vascular lesions or eliminate surveillance needs.
48.How can the ocular phenotype guide systemic investigation in recurrent anterior uveitis?
Begin by defining the phenotype, including anatomical site, onset, laterality and recurrence. Recurrent acute anterior uveitis, often affecting one eye at a time, can accompany HLA-B27-associated spondyloarthritis. Inflammatory back pain, peripheral arthritis, psoriasis or inflammatory bowel symptoms strengthen the reason for systemic assessment. HLA-B27 testing can support this evaluation, but it is a susceptibility marker rather than a stand-alone diagnosis. Its presence does not prove that it caused the ocular inflammation, and its absence does not exclude spondyloarthritis.
Apply it
A patient with recurrent acute unilateral anterior uveitis reports morning back stiffness that improves with activity and recurrent bloody diarrhoea. Select HLA-B27 testing and rheumatological assessment for possible spondyloarthritis; the bowel symptoms also warrant gastroenterological assessment for inflammatory bowel disease. Sacroiliac imaging may be selected during the systemic assessment when axial disease is suspected. HLA-B27 testing does not diagnose inflammatory bowel disease.
Common pitfall: Do not close the diagnosis after a positive HLA-B27 result. The ocular pattern, systemic history, examination and relevant investigations must agree. Infectious explanations still require consideration when the clinical findings support them.
National Eye Institute: Uveitis · EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases · AAOSub_2022_RET_Syllabus_Uveitis.pdf
Ophthalmic Pathology, Microbiology and Immunologynot stated
49.How do RB1 alterations explain retinoblastoma development?
RB1 is a tumour-suppressor gene, and retinoblastoma commonly develops after loss of functional activity in both copies within a susceptible retinal cell. In heritable disease, a pathogenic alteration is present constitutionally, so an additional cellular event can initiate a tumour. In nonheritable disease, the relevant alterations arise within the tumour lineage. This distinction connects molecular mechanism to bilateral or multifocal risk, family assessment and surveillance; it is not adequately described as a simple inherited tendency to poor vision.
Apply it
A family asks why a child with a constitutional RB1 alteration may develop more than one retinal tumour. Explain that many retinal cells share the first alteration, allowing separate additional events to generate independent tumours.
Common pitfall: Tumour-suppressor loss is not the same mechanism as activation of a single oncogene. The constitutional alteration also does not mean every retinal cell is already malignant.
50.Why does unilateral retinoblastoma not exclude heritable disease?
Bilateral or multifocal retinoblastoma strongly raises concern for a constitutional RB1 alteration, but unilateral presentation does not eliminate that possibility. Family history can also be absent when a pathogenic alteration arises newly or when other genetic circumstances apply. Genetic assessment therefore refines risk beyond laterality alone and can affect surveillance for the child and counselling of relatives. A unilateral tumour should not be labelled nonheritable solely because the fellow eye is normal at the first examination.
Apply it
An infant has unilateral retinoblastoma and no affected relatives. Explain why genetic counselling and appropriate testing still matter, rather than offering definitive reassurance that siblings and future offspring cannot be affected.
Common pitfall: No family history does not establish a nonheritable tumour. Likewise, unilateral disease is a clinical description rather than a complete genetic classification.
51.Why is suspected retinoblastoma investigated without routine intraocular biopsy?
Retinoblastoma assessment uses specialist ocular examination and imaging to establish the diagnosis and extent while avoiding procedures that could spread tumour outside the eye. Leukocoria and strabismus are important presenting clues, but neither alone establishes the diagnosis. The EBO pathology syllabus specifically identifies retinoblastoma as a setting where biopsy is contraindicated. Diagnostic planning must therefore recognise that the usual impulse to obtain tissue before treating a tumour can be inappropriate for this particular intraocular malignancy.
Apply it
A child with leukocoria has an intraocular mass suspicious for retinoblastoma. Refer for specialist examination and imaging rather than arranging a needle biopsy simply to obtain histological confirmation before further assessment.
Common pitfall: The general principle of tissue diagnosis has important anatomical exceptions. Applying it automatically to suspected retinoblastoma risks tumour dissemination and does not reflect its established diagnostic pathway.
NCI: Retinoblastoma Treatment—Health Professional Version · EBO syllabus: Ophthalmic pathology and oncology
52.Which exposures support investigation for fungal keratitis?
Fungal keratitis can follow corneal injury, particularly trauma involving plant material, and can also occur in association with contact-lens wear. Exposure history changes suspicion but cannot reliably identify the organism by itself. Corneal sampling can support microscopy and culture, helping distinguish fungal infection from bacterial or other causes of an ulcer. Unnecessary corticosteroid use can worsen fungal disease, so an inflammatory appearance should not lead directly to treatment that suppresses the host response without addressing infection.
Apply it
A gardener develops a painful corneal lesion after being struck by a plant stem. Include fungal infection in the differential and obtain appropriate corneal diagnostic material rather than inferring a sterile reaction from the trauma history.
Common pitfall: Plant trauma increases suspicion but is not a microbiological result. Treating the appearance alone can miss the organism and expose an infected cornea to harmful unnecessary corticosteroids.
CDC: Fungal Eye Infections Basics · CDC: What Causes Fungal Keratitis
53.How can bloodstream infection reach the eye?
Fungal organisms can reach internal ocular tissues through the bloodstream, producing endogenous infection without preceding corneal trauma or eye surgery. This route differs from infection introduced directly through an injured ocular surface or a procedure. Relevant systemic infection and host factors therefore belong in the history when new visual symptoms develop. The absence of a local entry wound is not reassuring in a patient with bloodstream infection, and ocular assessment must consider deeper structures rather than only the corneal surface.
Apply it
A hospitalised patient with a fungal bloodstream infection develops new floaters and blurred vision without ocular trauma. Consider haematogenous ocular involvement and arrange assessment of the posterior segment and other affected structures.
Common pitfall: Searching only for a corneal wound misses endogenous infection. A normal-looking ocular surface cannot exclude infection within the eye in a patient with relevant systemic disease.
54.Why does specimen handling depend on the diagnostic question?
Histology, microbiology and molecular testing answer different questions and may require different specimen preparation. Preserving tissue architecture for histology is not the same as maintaining viable organisms for culture. The intended tests should therefore be agreed before collection, with appropriate material allocated and labelled for the receiving laboratory. This is a diagnostic decision rather than a clerical detail: a technically successful sampling procedure can still fail if all material is handled in a way that prevents the required investigation.
Apply it
An ocular specimen is intended for both histology and microbial culture. Confirm handling requirements with the laboratory before collection so that material for culture is not all placed into a histological fixative.
Common pitfall: One container is not suitable for every diagnostic purpose. More tissue cannot compensate for processing that destroys the property the requested test needs to examine.
Pharmacology and Therapeuticsnot stated
55.Why can topical timolol produce systemic effects?
Timolol is a nonselective beta-adrenergic blocker used in the eye to reduce intraocular pressure through reduced aqueous production. Ophthalmic administration does not confine its action to the eye: systemic absorption can produce effects associated with beta-blockade elsewhere, including cardiovascular and respiratory effects. A medication history must therefore include eye drops when evaluating a new slow pulse, breathing symptoms or interacting therapy. Route of administration changes delivery but does not remove the drug's receptor pharmacology or relevant systemic precautions.
Apply it
A patient develops a slower pulse after an ophthalmic pressure-lowering medicine is added. Identify timolol among possible contributors and review the entire medication list rather than excluding eye drops from the adverse-effect assessment.
Common pitfall: Calling a medicine topical does not establish negligible systemic exposure. Unexplained symptoms can be missed when ophthalmic preparations are omitted from medication reconciliation.
56.Which systemic conditions make ophthalmic timolol unsuitable?
The cited timolol label lists bronchial asthma or its history, severe chronic obstructive pulmonary disease, sinus bradycardia, second- or third-degree atrioventricular block, overt cardiac failure and cardiogenic shock among contraindications. These restrictions reflect systemic nonselective beta-blockade despite ocular dosing. Selection therefore requires more than checking the pressure-lowering effect. A history of asthma remains important even if the patient is not wheezing during the visit, and a low resting pulse deserves attention before treatment begins.
Apply it
A patient needing pressure reduction has a documented history of asthma and currently clear lungs. Recognise that the history still matters under the label and select a suitable alternative rather than trialling timolol because today's examination is normal.
Common pitfall: Absence of current bronchospasm does not remove a history-based contraindication. Pressure-lowering efficacy cannot compensate for an avoidable systemic safety problem.
57.How does latanoprost lower intraocular pressure?
Latanoprost is a prostaglandin F2α analogue whose active acid acts at prostanoid FP receptors. Its pressure-lowering effect is associated with increased aqueous humour outflow, particularly through the uveoscleral pathway. This mechanism differs from reducing aqueous formation through beta-blockade. Recognising the distinction helps candidates explain drug classes and avoid attributing every pressure-lowering medicine to the same site of action. Mechanism also does not replace assessment of effectiveness, tolerability and the individual patient's ocular circumstances.
Apply it
A patient asks whether latanoprost works by slowing fluid production like a previously prescribed beta-blocker. Explain that its principal action increases fluid outflow, then assess the actual pressure response at follow-up.
Common pitfall: Grouping all glaucoma drops as aqueous suppressants loses a clinically useful distinction. A correct mechanism also does not guarantee that a particular eye has reached its target pressure.
58.How should latanoprost-related pigmentation be explained?
Latanoprost can increase iris pigmentation through increased melanin content in melanocytes. The change may be permanent, and unilateral treatment can make an interocular difference more noticeable. Eyelid pigmentation and eyelash changes are additional recognised effects with different courses after discontinuation. Counselling should distinguish these expected medication-related changes from symptoms suggesting another disorder. Explaining the possibility before treatment supports informed use and prevents a gradual colour change from being mistaken for evidence that pressure control has failed.
Apply it
A patient using latanoprost in one eye notices gradual darkening of that iris. Review the change and explain the recognised pigmentation effect, including possible persistence, while separately evaluating pressure control and any new symptoms.
Common pitfall: Do not promise that iris colour will return to baseline after stopping treatment. Pigmentation change is also not a measure of how effectively the pressure has fallen.
59.Why must an eye-drop tip avoid contact with surrounding surfaces?
A multidose ophthalmic container can become contaminated when its tip contacts the eye, fingers or another surface. Subsequent instillation can introduce contaminated fluid to the ocular surface, and bacterial keratitis has been associated with contaminated ophthalmic products. The latanoprost label therefore includes handling advice that protects the container tip. Technique counselling should be specific and observed when possible: knowing the name and schedule of a medicine does not establish that the patient can administer it without contaminating the bottle.
Apply it
During a demonstration, a patient rests the dropper directly on the lower lid to improve aim. Teach a technique that avoids tip contact and assess whether an administration aid would help the patient use drops consistently.
Common pitfall: A preserved solution is not immune to contamination. Touching the tip to stabilise the bottle trades a perceived aiming benefit for an avoidable source of infection risk.
60.Why does corticosteroid treatment require ocular monitoring?
Corticosteroids can control damaging inflammation but can also cause important ocular complications, including raised intraocular pressure and cataract. Treatment response therefore has more than one dimension: reduced cells or pain does not establish that therapy is free of harm. Monitoring is guided by the disease, exposure and patient factors, with reassessment of pressure and lens status when relevant. Infection must also remain part of diagnostic reasoning because suppressing inflammation is not equivalent to treating an infectious cause.
Apply it
A patient with uveitis feels better on corticosteroids but develops elevated pressure at review. Recognise treatment-related harm as a possible contributor while reassessing inflammatory activity and the balance between disease control and adverse effects.
Common pitfall: Symptom relief is not a complete safety assessment. Continuing unchanged treatment solely because the eye is quieter can overlook pressure-related damage or other accumulating complications.
National Eye Institute: Uveitis · CDC: What Causes Fungal Keratitis
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use units, signs and meridional power explicitly in lens, vertex-distance and prism calculations.
- Separate visual rehabilitation from control of disease progression in amblyopia, ectasia and glaucoma.
- Localise abnormalities before naming causes: anterior versus posterior inflammation, afferent versus efferent pupil defects, and chiasmal versus retrochiasmal field loss.
- Recognise time-sensitive patterns involving retinal detachment, orbital infection, dysthyroid optic neuropathy and arteritic visual ischaemia.
- Connect treatment to mechanism, contraindications and monitoring rather than recalling drug names alone.
- Practise concise case answers that identify decisive findings, a supported differential and the investigation that would change management.
- Use the complete official syllabus to extend preparation beyond this selective set, including the developmental, traumatic, neoplastic and preventive topics assessed across stations.
A practical preparation plan
1. Map the full syllabus
Build a study map from the ten written themes and eight linked EBO syllabus documents. Mark topics covered here and identify remaining areas, rather than treating 60 concepts as a complete specialist curriculum.
2. Work calculations from first principles
Practise focal-length conversion, image formation, principal meridional powers, Prentice's rule and vertex conversion. Write the units and predict the direction of the effect before calculating.
3. Build discriminating clinical pairs
Compare tropia with phoria, orbital with preseptal infection, tractional with rhegmatogenous detachment, and afferent with efferent pupillary dysfunction. For each pair, state the finding that changes the next decision.
4. Answer and analyse the SBA drills
Complete the 20 questions independently, then explain why each alternative is less appropriate. Classify errors as missing knowledge, misread clinical cues, faulty localisation or unsupported assumptions.
5. Practise both real written formats
Alongside SBA practice, judge individual true/false statements independently and explain the mechanism supporting each judgement. Use issuer materials to familiarise yourself with the actual examination interface.
6. Rehearse the four clinical subject groups
Use unfamiliar cases to practise describing findings, localising disease, naming supported differentials, selecting investigations and proposing management. Answer the question asked before moving to later decisions, and distinguish urgent action from confirmatory investigation.
7. Revisit weak mechanisms with active recall
Use the flashcards to explain mechanisms aloud, then change one case feature and reconsider the answer. Recheck the current issuer instructions for your sitting separately from clinical study.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- EBOD Exams
- Structure of Examination
- EBOD Exam: Candidate Handbook 2026
- Syllabus & Recommended Reading
- EBO syllabus: Optics and Refraction
- EBO syllabus: Paediatric Ophthalmology and Strabismus
- EBO syllabus: External Disease, Cornea, Cataract, Refractive surgery
- EBO syllabus: Glaucoma
- EBO syllabus: Intraocular inflammation, uveitis, vitreoretinal diseases
- EBO syllabus: Neuro Ophthalmology
- EBO syllabus: Eyelids, Lacrimal system, Orbit
- EBO syllabus: Ophthalmic pathology and oncology
- OpenStax Physics: 16.3 Lenses
- National Academy of Opticianry: Prentice's Rule and Finding the Power of a Lens in Any Meridian
- AAPOS: Accommodative Esotropia
- AAPOS: Amblyopia
- College of Optometrists: Herpes simplex keratitis
- FDA: PHOTREXA VISCOUS and PHOTREXA prescribing information, revised February 2025
- European Glaucoma Society: Setting the Target IOP
- ESCRS Recommendations for Cataract Surgery
- NIH: Retinal Detachment
- National Eye Institute: Uveitis
- Stanford Neuro-Ophthalmology: Visual Fields
- Stanford Neuro-Ophthalmology: Pupils—Examination, Anatomy and Physiology
- AAPOS: Cellulitis
- Management of Thyroid Eye Disease: ATA–ETA Consensus Statement, 2022
- 2021 ACR/Vasculitis Foundation Guideline for Giant Cell Arteritis and Takayasu Arteritis
- National Eye Institute: Diabetic Retinopathy
- NCI: Retinoblastoma Treatment—Health Professional Version
- CDC: What Causes Fungal Keratitis
- CDC: Fungal Eye Infections Basics
- DailyMed: Timolol Maleate Ophthalmic Solution
- DailyMed: Latanoprost Solution
- Vertex-Distance-Effective-Power-Compensated-Power-Tilt-Wrap.pdf
- European Glaucoma Society
- AAOSub_2022_RET_Syllabus_Uveitis.pdf
- Atlas Entry - Fungal keratitis
- DailyMed - PILOCARPINE HYDROCHLORIDE- pilocarpine hydrochloride ophthalmic solution solution/ drops
- DailyMed - COSOPT- dorzolamide hydrochloride and timolol maleate solution/ drops
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.